SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle .
Format / Length
an2
Description
National Codes
| Code | Description |
|---|---|
|
01 |
Intravenous |
|
02 |
Oral |
|
03 |
Intrathecal |
|
04 |
Intramuscular |
|
05 |
Subcutaneous |
|
06 |
Intraarterial |
|
07 |
Intraperitoneal |
|
08 |
Other intracavity Intracavernous |
|
09 |
Intravesical (Intra-Vesicular) |
|
10 |
Intratumour / Intralesional (Retired 1 September 2019 ) |
|
11 |
Cutaneous (Topical) |
|
12 |
Intradermal |
|
13 |
Intratumour |
|
14 |
Intralesional |
|
99 |
Other (Retired 1 September 2019 ) |
|
98 |
Other (not listed) |
Also Known As
This data element is also known by these names:
| Context | Alias |
|---|---|
| Plural | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTES OF ADMINISTRATION |
Where Used
| Type | Link | How used |
|---|---|---|
| Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |